These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7330498)

  • 1. [Maple syrup urine disease. Genetic heterogeneity, heterozygote diagnosis and new therapeutic approach (author's transl)].
    Velázquez A; Montiel F; Sahw KN; Carnevale A; del Castillo V
    Rev Invest Clin; 1981; 33(3):273-9. PubMed ID: 7330498
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biochemical studies in a patient with maple syrup urine disease (author's transl)].
    Vaca G; Rivas F; Sánchez-Corona J; Olivares N; Aguirre-Negrete MG; González-Quiroga G; Medina C; Hernández A; Cantú JM
    Rev Invest Clin; 1981; 33(4):379-82. PubMed ID: 7330511
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of thiamin in maple syrup urine disease.
    Elsas LJ; Danner DJ
    Ann N Y Acad Sci; 1982; 378():404-21. PubMed ID: 7044230
    [No Abstract]   [Full Text] [Related]  

  • 4. Heterozygote detection for maple syrup urine disease in cattle.
    Healy PJ; Dennis JA
    Aust Vet J; 1995 Sep; 72(9):346-8. PubMed ID: 8585849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis of intermittent maple syrup urine disease: novel mutations in the E2 gene of the branched-chain alpha-keto acid dehydrogenase complex.
    Tsuruta M; Mitsubuchi H; Mardy S; Miura Y; Hayashida Y; Kinugasa A; Ishitsu T; Matsuda I; Indo Y
    J Hum Genet; 1998; 43(2):91-100. PubMed ID: 9621512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiamine response in maple syrup urine disease.
    Fernhoff PM; Lubitz D; Danner DJ; Dembure PP; Schwartz HP; Hillman R; Bier DM; Elsas LJ
    Pediatr Res; 1985 Oct; 19(10):1011-6. PubMed ID: 3903643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maple syrup urine disease in a Bedouin tribe: pre- and postnatal diagnosis.
    Potashnik R; Carmi R; Sofer S; Bashan N; Abeliovich D
    Isr J Med Sci; 1987 Aug; 23(8):886-9. PubMed ID: 3679791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Maple syrup urine disease].
    Indo Y; Matsuda I
    Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):201-4. PubMed ID: 9590028
    [No Abstract]   [Full Text] [Related]  

  • 9. Maple syrup urine disease: metabolic decompensation monitored by proton magnetic resonance imaging and spectroscopy.
    Felber SR; Sperl W; Chemelli A; Murr C; Wendel U
    Ann Neurol; 1993 Apr; 33(4):396-401. PubMed ID: 8489211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Maple syrup urine disease].
    Indo Y
    Nihon Rinsho; 2002 Apr; 60 Suppl 4():783-7. PubMed ID: 12013999
    [No Abstract]   [Full Text] [Related]  

  • 11. Branched-chain alpha-keto acids for the diagnosis of maple-syrup-urine disease.
    Parsons H; Fung E; Snyder FF
    N Engl J Med; 1987 Apr; 316(15):951. PubMed ID: 3821846
    [No Abstract]   [Full Text] [Related]  

  • 12. Maple syrup urine disease in calves: a clinical, pathological and biochemical study.
    Harper PA; Dennis JA; Healy PJ; Brown GK
    Aust Vet J; 1989 Feb; 66(2):46-9. PubMed ID: 2712767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Maple syrup urine disease: report of a mild variant case and results of dietary treatment].
    Stoppoloni G; Santinelli R; Prisco F; Tolone C; D'Ambrosio M
    Pediatria (Napoli); 1978 Sep; 86(3):409-20. PubMed ID: 754161
    [No Abstract]   [Full Text] [Related]  

  • 14. MR diffusion imaging and MR spectroscopy of maple syrup urine disease during acute metabolic decompensation.
    Jan W; Zimmerman RA; Wang ZJ; Berry GT; Kaplan PB; Kaye EM
    Neuroradiology; 2003 Jun; 45(6):393-9. PubMed ID: 12736767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Family with intermittent maple syrup urine disease.
    Valman HB; Patrick AD; Seakins JW; Platt JW; Gompertz D
    Arch Dis Child; 1973 Mar; 48(3):225-8. PubMed ID: 4693464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Maple syrup urine disease: molecular pathology of the branched chain alpha-keto acid dehydrogenase complex].
    Nobukuni Y; Mitsubuchi H; Indo Y; Endo F; Matsuda I
    Seikagaku; 1992 Feb; 64(2):67-82. PubMed ID: 1593184
    [No Abstract]   [Full Text] [Related]  

  • 17. Correlations between branched-chain amino acids and branched-chain alpha-keto acids in blood in maple syrup urine disease.
    Langenbeck U; Wendel U; Mench-Hoinowski A; Kuschel D; Becker K; Przyrembel H; Bremer HJ
    Clin Chim Acta; 1978 Sep; 88(2):283-91. PubMed ID: 699323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [3 patients with maple syrup urine disease].
    Merinero B; del Valle JA; García MJ; García Miguel MJ; Barrio MI; García Hortelano J; Morales E; González F; García Aparicio J; Sáez Pérez E
    An Esp Pediatr; 1983 Nov; 19(5):393-400. PubMed ID: 6660657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal models of maple syrup urine disease.
    Skvorak KJ
    J Inherit Metab Dis; 2009 Apr; 32(2):229-46. PubMed ID: 19263237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Isolated isoleucine deficiency in diet therapy of a case of maple syrup urine disease].
    Sanjurjo P; Centeno C; Vallo A; Ojembarrena E; Rodríguez Soriano J
    An Esp Pediatr; 1983 Nov; 19(5):389-92. PubMed ID: 6660656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.